<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01885091</url>
  </required_header>
  <id_info>
    <org_study_id>K.I.S.S</org_study_id>
    <nct_id>NCT01885091</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety Study of Kinerase® for Treatment of Cutaneous Facial Photodamage</brief_title>
  <official_title>Kinerase® Interactive Skin-care Study: A Multicentre, Phase IV, Single-arm, Open-label Trial to Evaluate the Efficacy and Safety of Kinetin, N6-furfuryladenine, 0.1% for Treatment of Cutaneous Facial Photodamage</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Menarini (Thailand) Limited</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Menarini (Thailand) Limited</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the K.I.S.S. study is to evaluate the efficacy of Kinerase® Cream (Kinetin
      0.1%) in Thai patients, on the basis of the severity and clinical signs of facial
      photodamage.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2012</start_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To assess the physician's evaluation and patient's self-evaluation at 12 weeks.</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the physician's evaluation and patient's self-evaluation at 4 weeks.</measure>
    <time_frame>4 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the physician's evaluation and patient's self-evaluation at 8 weeks.</measure>
    <time_frame>8 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Skin Roughness</condition>
  <condition>Mottling</condition>
  <condition>Blotchiness</condition>
  <condition>Pigmentation</condition>
  <condition>Fine Wrinkles</condition>
  <arm_group>
    <arm_group_label>Kinerase</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Kinerase</intervention_name>
    <arm_group_label>Kinerase</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male and female subjects older than 35 years of age and less than 65 years of age.

          2. Subjects with mild, moderate or severe facial photodamage as assessed by a 10-point
             scale.

          3. Subjects willing to sign an informed consent and adhere to all protocol requirements.

        Exclusion Criteria:

          1. Male and female subjects with suspected porphyria, systemic or cutaneous erythematosus
             lupus, or any other photosensitizing disorder or drug-induced photosensitization.

          2. Subjects with chronic or recurring skin disease or disorder.

          3. Subjects with any active infectious skin disorder (Herpes simplex, molluscum
             contagiosum, and facial warts).

          4. Subjects with skin cancer of the facial tissues.

          5. Subjects who have received any laser/ intense pulsed light (IPL) / chemical peel in
             the 2 months preceding the screening visit.

          6. Subjects with a history of topical and/or oral isotretinoin use, 6 months prior to the
             screening visit.

          7. Subjects who have been on topical Retin-A or Renova in the 2 months prior to the
             screening visit.

          8. Subjects who have used topical alpha-hydroxy acid skin care products in the month
             preceding the screening visit.

          9. Subjects currently on any anti-aging products and who wish to continue use of their
             products.

         10. Subjects requiring concurrent treatment that would interfere with the study
             assessments.

         11. Pregnant or lactating female subjects.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rungsima Wanitphakdeedecha, MD, MA, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>iSKY Innovative Skin &amp; Laser Surgery Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>I-Sky Center Chidlom branch</name>
      <address>
        <city>Bangkok</city>
        <zip>10500</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 20, 2013</study_first_submitted>
  <study_first_submitted_qc>June 20, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 24, 2013</study_first_posted>
  <last_update_submitted>June 23, 2013</last_update_submitted>
  <last_update_submitted_qc>June 23, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 25, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kinetin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

